Supriya Life Sciences Balance Sheet Annual

Trade

BSE: 543434 | NSE: SUPRIYA | ISIN: INE07RO01027 | Sector: Biotechnology & Drugs

792.40 -9.40 (-1.17%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	68.35	69.55	142.62	42.62
Short Term Investments	11.12	86.62	68.16	48.80
Cashand Short Term Investments	79.47	163.99	233.94	92.29
Accounts Receivable- Trade Net	111.68	84.66	115.18	73.50
Total Receivables Net	112.37	152.26	132.74	82.58
Total Inventory	85.25	115.77	92.31	72.48
Other Current Assets Total	120.72	22.02	31.31	17.11
Total Current Assets	397.80	464.89	497.54	265.46
Property/ Plant/ Equipment Total- Gross	148.83	371.35	263.57	199.21
Property/ Plant/ Equipment Total- Net	457.30	328.06	231.67	177.21
Intangibles Net	1.66	1.11	1.51	1.61
Long Term Investments	63.80	25.30	0.05	0.05
Other Long Term Assets Total	0.68	0.93	3.98	1.12
Total Assets	921.24	820.28	734.76	445.47
Accounts Payable	59.57	64.23	48.97	51.02
Accrued Expenses	0.37	0.84	0.41	0.91
Notes Payable/ Short Term Debt	0.00	16.63	21.30	67.41
Current Portof LT Debt/ Capital Leases	0.47	0.35	0.83	2.72
Other Currentliabilities Total	16.49	13.74	28.20	23.96
Total Current Liabilities	76.89	95.78	99.70	146.02
Long Term Debt	0.00	0.00	0.00	0.00
Capital Lease Obligations	5.02	5.49	5.30	2.07
Total Long Term Debt	5.02	5.49	5.30	2.07
Total Debt	5.49	22.47	27.42	72.20
Deferred Income Tax	23.15	13.68	11.15	8.01
Other Liabilities Total	0.81	5.88	2.93	20.79
Total Liabilities	105.87	120.82	119.08	176.88
Common Stock Total	16.10	16.10	16.10	14.64
Retained Earnings( Accumulated Deficit)	799.27	683.36	599.59	253.95
Total Equity	815.37	699.46	615.69	268.58
Total Liabilities Shareholders' Equity	921.24	820.28	734.76	445.47
Total Common Shares Outstanding	8.05	8.05	8.05	7.32
Tangible Book Valueper Share Common Eq	101.10	86.77	76.31	36.48
Cash	-	7.82	23.16	0.88
Prepaid Expenses	-	10.85	7.25	1.00
Accumulated Depreciation Total	-	-43.29	-31.90	-21.99
Other Equity Total	-	0.00	0.00	-
Note Receivable- Long Term	-	-	0.00	0.00